The global health and wellness company XpresSpa Group, Inc. (Nasdaq: XSPA) has been seeing stock rising 16.05% (as of 08:10 a.m. EST) in pre-market trading today. The stock is likely to be continuing the rally began on the weekend when it came rising 3.85% to close the Friday trading at $1.62. Apparently, there has been no directly linked news that could drive the move.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
XpresSpa is the company’s primary asset. With 45 locations in 23 airports globally, XpresSpa is a leading airport retailer of spa services and related products. At seven locations in six airports, the Company provides COVID-19 screening and testing under the XpresCheck brand through its subsidiary XpresTest, Inc. They feature one outlet each at JFK International Airport, Newark Liberty International Airport, Phoenix Sky Harbor International Airport, Denver International Airport, Salt Lake City International Airport, and two outlets at Logan International Airport.
XpresSpa announced last Thursday that it has signed a contract with Seattle-Tacoma International Airport (SEA) to create an XpresCheck COVID-19 pop-up testing facility.
- It is expected to be fully operational by mid-March, and is the first testing facility of the Company on the West Coast.
- Pre-security in Baggage Claim near Carousel 9 will be equipped with a pop-up checkpoint, and the service will be provided by XpresCheck.
- It will have a capacity to administer 500 tests per day across eight separate testing rooms.
- Various methods of COVID-19 testing will be available, including Polymerase Chain Reaction (PCR) Test and Rapid Molecular COVID-19 Test.